SCHEMBL25819339

SCHEMBL25819339

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccccc4)nc(-c4cccc5c4C4(c6c-5ccc5c6oc6c7ccccc7ccc56)C5CC6CC(C5)CC4C6)n3)c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 9/20 0.33
CYP1A2 P05177 9/20 0.33
CYP1B1 Q16678 9/20 0.33
KDM4E B2RXH2 3/20 0.33
PRKDC P78527 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
PDE5A O76074 1/20 0.33
ABCB1 P08183 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818202 0.91 CYP1A1 (0.32) CYP1A1CYP1A2CYP1B1KDM4EPRKDC
SCHEMBL25817527 0.84 TSHR (0.35) CYP1A2KDM4EPRKDCALDH1A1TP53
SCHEMBL25818196 0.81 HTT (0.32) CYP1A1CYP1A2CYP1B1KDM4EPRKDC
SCHEMBL25037703 0.80 PDE7A (0.33) KDM4EALDH1A1TP53MAPTHPGD
SCHEMBL25035885 0.80 MAPT (0.34) KDM4EALDH1A1TP53MAPTHPGD
SCHEMBL25878333 0.79 PRKDC (0.38) CYP1A2KDM4EPRKDCALDH1A1MAPT
SCHEMBL26050987 0.79 ALOX5 (0.35) KDM4EPRKDCALDH1A1TP53MAPT
SCHEMBL26272084 0.79 HTT (0.39) CYP1A1CYP1A2CYP1B1KDM4EPRKDC
SCHEMBL25038214 0.78 KDM4E (0.31) KDM4EALDH1A1TP53MAPTHPGD
SCHEMBL25038404 0.78 HSD17B1 (0.34) CYP1A1CYP1A2CYP1B1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, AOC2, EPCAM CYP1A1 1060/4885CYP1A2 585/4885CYP1B1 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.